The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Merck announced a collaboration with Washington University in St. Louis, Missouri that could lead to the optimizing of nutritional supplements to ...
read more
Alkahest announced the initiation of two Phase 2 clinical trials of ALK4290 in patients with the wet form of age-related macular degeneration.
read more
Taiho Oncology and Servier announced the pivotal Phase 3 trial evaluating LONSURF plus best supportive care versus placebo plus BSC in patients with ...
read more
Provention has acquired all rights to teplizumab to be further developed as PRV-031 and licensing rights to MGD010 for development as PRV-3279.
read more
Debiopharm announced the FDA has granted Fast Track designation to Debio 1347, an FGFR 1-3 Inhibitor, for the treatment of patients with unresectable ...
read more
Nektar Therapeutics has commenced dosing patients with systemic lupus erythematosus (SLE) in a Phase 1b clinical study evaluating NKTR-358, a first-in...
read more
PaxVax has received Fast Track designation from the FDA for its vaccine for the prevention of disease caused by the chikungunya virus.
read more
Forty Seven announced the FDA has granted two Fast Track designations to its lead candidate, 5F9, for the treatment of relapsed or refractory DLBCL ...
read more
Merck KGaA, Darmstadt, Germany announced a development agreement for investigational molecule abituzumab with SFJ Pharmaceuticals Group.
read more
Arena and Outpost Medicine announced they have entered into a licensing agreement to advance an undisclosed, preclinical compound with potential ...
read more
Sangamo announced the California Institute for Regenerative Medicine has awarded an $8 million grant for Sangamo to evaluate ST-400.
read more
Wednesday, April 25, 2018
Following successful Phase 1 clinical trials of a new immunotherapy for patients with recurrent brain cancer, the Toca regimen trial has advanced to a...
read more
Nektar has entered into a new clinical collaboration with Takeda to evaluate NKTR-214 with TAK-659 as a potential combination treatment regimen in ...
read more
Lin BioScience announced the FDA has granted Orphan Drug Designation to LBS-007 for acute lymphoblastic leukemia.
read more
UCB announced an agreement to acquire the rights to Proximagen's Midazolam Nasal Spray, an AED developed as an intended rescue treatment for acute ...
read more